Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Apr;144(4):683-92.

Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells

D D Sedmak  1 , A M Guglielmo, D A Knight, D J Birmingham, E H Huang, W J Waldman
Affiliations

Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells

D D Sedmak et al. Am J Pathol. 1994 Apr.

Abstract

Persistent human cytomegalovirus (HCMV) infections are responsible for significant morbidity and mortality in immunocompromised individuals. One mechanism by which HCMV may develop persistence after primary infection is through inhibition of host cell human leukocyte antigen (HLA) class II expression with resultant escape from normal antiviral immune surveillance. Immunofluorescence flow cytometry of human endothelial cell (EC) cultures infected with HCMV AD169 and an EC propagated strain, VHL/E, showed a marked reduction in interferon-gamma (IFN-gamma)-induced surface expression of HLA-DR. This inhibition did not occur when EC were treated with ultraviolet-inactivated virus and IFN-gamma. HCMV, as determined by dual-labeling immunohistochemistry, inhibited induction of surface and cytoplasmic class II antigens specifically in infected cells. HCMV infection also inhibited IFN-gamma and tumor necrosis factor-alpha up-regulation of HLA class I expression. Northern blot analysis of infected, IFN-gamma-treated human umbilical vein endothelial cells revealed an absence of class II mRNA. Persistence of HCMV may result in part from its ability to inhibit HLA class II induction in infected cells.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Clin Invest. 1973 Nov;52(11):2745-56 - PubMed
    1. J Cell Biol. 1974 Mar;60(3):673-84 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5674-8 - PubMed
    1. J Exp Med. 1980 Aug 1;152(2 Pt 2):249s-255s - PubMed
    1. Rev Infect Dis. 1983 Mar-Apr;5(2):205-15 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources